Why is this ASX 200 stock crashing 30% today?

What's going with this stock? Let's find out why its shares are deep in the red.

| More on:
A man holds his head in his hands, despairing at the bad result he's reading on his computer.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Healius Ltd (ASX: HLS) shares are ending the week deep in the red.

In morning trade, the ASX 200 stock is down 30% to a 52-week low of $1.07.

As a comparison, the benchmark ASX 200 index is up 0.15% at the time of writing.

Why is this ASX 200 stock crashing 30%?

The good news for shareholders is that today's massive decline in the Healius share price is not because of a bad update nor a broker downgrade.

In fact, today's big decline could arguably be good news for them.

That's because the decline has been driven by the healthcare company's shares going ex-dividend this morning for a very special dividend.

When a share goes ex-dividend, it means that the rights to an upcoming dividend payment are now settled. As a result, anyone buying this ASX 200 stock today will not be entitled to receive the Healius dividend when it is paid to shareholders. Instead, it will stay with the seller of the shares even though they no longer own them.

In light of this, a share price will usually drop to reflect this. After all, you don't want to pay for something that you won't receive.

The Healius dividend

Earlier this week, Healius announced plans to pay a special dividend following the completion of the sale of Lumus Imaging to funds managed by Affinity Equity Partners.

The ASX 200 stock received cash proceeds of $822 million, which represented an $965 million enterprise value when adjusted for the repayment of equipment leases and closing adjustments.

Net proceeds are expected to be in excess of $800 million after all transaction fees, separation costs and other fees.

Unfortunately, not all of these funds will be returned to shareholders, but a good portion will be.

The ASX 200 stock is returning $300 million to shareholders through a fully franked special dividend of 41.3 cents per share. Those franking credits equate to 17.7 cents per share or approximately $128 million.

Based on where the Healius share price finished yesterday's session, this equates to a stunning 26.8% fully franked dividend yield.

To put that into context, a $5,000 investment in its shares yesterday would generate approximately $1,340 in dividends.

When is pay day?

The ASX 200 stock's eligible shareholders won't have to wait long for pay day.

The healthcare company is planning to pay this monster dividend to shareholders in two weeks on 23 May.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Business people discussing project on digital tablet.
Healthcare Shares

Where will CSL shares be in 5 years?

Would it be a good time to buy and hold this fallen giant? Let's find out.

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Up 657% in a year, 4DMedcial shares rocketing another 20% today on big US news

ASX investors can’t get enough of 4DMedical shares today. Let’s see why.

Read more »

Health professional working on his laptop.
Healthcare Shares

NIB shares edge higher on profit update

Let's see why this private health insurer is in the news today.

Read more »

Researchers and doctors with futuristic 3d hologram overlay for body anatomy or dna in hospital clinic.
Healthcare Shares

Bell Potter names the best ASX healthcare shares to buy in 2026

Healthy returns could be on offer with these shares according to the broker.

Read more »

man cupping ear as if to listen closely, rumour, cochlear
Healthcare Shares

Why is everyone talking about Telix shares this week?

Let's see why this biotech stock has been on the move this week.

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

This ASX stock is going parabolic, and I think it's still a buy

4DMedical shares are up nearly 500% in 2025, but improving revenue visibility suggests the growth story may not be over.

Read more »

ecommerce asx shares represented by santa doing online shopping on laptop
Healthcare Shares

Looking for ideas before Christmas? These 2 ASX shares stand out to me

Two ASX shares at opposite ends of the market are catching my attention as the year draws to a close.

Read more »

A doctor or medical expert in COVID protection adjusts her glasses, indicating growth or strong share price movement in ASX medical, biotech and health companies
Opinions

Forget CSL shares, I'd buy this booming biotech stock instead

This ASX biotech stock has caught my eye this year.

Read more »